Inhibition of NF-κB Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells

Cholangiocarcinoma (CCA) is a dismal cancer. At present, there is no effective chemotherapeutic regimen for CCA. This may be due to the marked resistance of CCA to chemotherapy drugs, for which a mechanism remains unknown. Nuclear factor-κB (NF-κB) is constitutively activated in a variety of cancer...

Full description

Saved in:
Bibliographic Details
Published in:Oncol Res
Main Authors: Seubwai, Wunchana, Vaeteewoottacharn, Kulthida, Kraiklang, Ratthaphol, Umezawa, Kazuo, Okada, Seiji, Wongkham, Sopit
Format: Artigo
Language:Inglês
Published: Cognizant Communication Corporation 2016
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7842550/
https://ncbi.nlm.nih.gov/pubmed/26802647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3727/096504015X14424348426071
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items